Literature DB >> 10030583

Fourth cranial nerve palsy in pediatric patients with pseudotumor cerebri.

C Speer1, J Pearlman, P H Phillips, M Cooney, M X Repka.   

Abstract

PURPOSE: To describe three children with acute fourth cranial nerve palsy secondary to pseudotumor cerebri.
METHODS: We reviewed the medical records of children younger than 18 years who were diagnosed with pseudotumor cerebri between 1977 and 1997. Pseudotumor cerebri was defined by normal neuro-imaging, elevated intracranial pressure measured by lumbar puncture, and normal cerebrospinal fluid composition.
RESULTS: Three children with pseudotumor cerebri presented with vertical diplopia and clinical signs of fourth cranial nerve palsy including a hypertropia of the affected eye, which increased with adduction and ipsilateral head tilt. The fourth cranial nerve palsy resolved after reduction of the intracranial pressure in all three children.
CONCLUSIONS: Fourth cranial nerve palsy may occur in children with pseudotumor cerebri and may be a nonspecific sign of elevated intracranial pressure.

Entities:  

Mesh:

Year:  1999        PMID: 10030583     DOI: 10.1016/s0002-9394(98)00422-x

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  4 in total

Review 1.  New developments in idiopathic intracranial hypertension.

Authors:  R K Shin; L J Balcer
Journal:  Curr Neurol Neurosci Rep       Date:  2001-09       Impact factor: 5.081

2.  Isolated fourth cranial nerve palsy due to pituitary macroadenoma.

Authors:  J Muthukrishnan; Khushboo Bharadwaj; Yashpal Singh
Journal:  Med J Armed Forces India       Date:  2016-03-29

3.  Idiopathic Intracranial Hypertension.

Authors:  Robert K. Shin; Laura J. Balcer
Journal:  Curr Treat Options Neurol       Date:  2002-07       Impact factor: 3.598

4.  Idiopathic Intracranial Hypertension: Etiological factors, Clinical Features, and Prognosis.

Authors:  Ahmet Onur KesKın; Fethi İdıman; Derya Kaya; Behice Bırcan
Journal:  Noro Psikiyatr Ars       Date:  2018-07-05       Impact factor: 1.339

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.